Archiv der Pharmazie

Article	Citations
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors	158
1,2,3‐Triazole hybrids as anticancer agents: A review	118
Coumarin derivatives with anticancer activities: An update	69
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity	68
Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors	66
Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3‐diaryltriazene‐substituted sulfathiazole derivatives	60
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds	60
Determination of the inhibition profiles of pyrazolyl–thiazole derivatives against aldose reductase and α‐glycosidase and molecular docking studies	59
1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities	55
Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives	53
Aromatase inhibitors: Role in postmenopausal breast cancer	46
Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors	46
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies	45
Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors	45
Synthesis and antidiabetic evaluation of benzimidazole‐tethered 1,2,3‐triazoles	43
Recent update on antibacterial and antifungal activity of quinoline scaffolds	43
Novel 2‐cyanoacrylamido‐4,5,6,7‐tetrahydrobenzo[b]thiophene derivatives as potent anticancer agents	42
Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms	37
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamides	37
Natural indole‐containing alkaloids and their antibacterial activities	37
Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1H,3H)‐dione bearing different moieties as VEGFR‐2 inhibitors	37
Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents	36
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations	35
Design, synthesis, molecular modeling, and antimicrobial potential of novel 3‐[(1H‐pyrazol‐3‐yl)imino]indolin‐2‐one derivatives as DNA gyrase inhibitors	34
5‐(4‐Methoxybenzylidene)thiazolidine‐2,4‐dione‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations	34

Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibit	32
Quinoline‐based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors	31
Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives	30
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents	30
Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking	29
New 1,2,3‐triazole–(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation	29
Synthesis of N‐alkylated pyrazolo[3,4‐d]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties	28
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors	28
Ecofriendly synthesis of pyrano[2,3‐d]pyrimidine derivatives and related heterocycles with anti‐inflammatory activities	28
Synthesis and biological evaluation of some 1‐naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors	27
Oxadiazole: A highly versatile scaffold in drug discovery	27
Synthesis and in silico studies of triazene‐substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors	26
Novel pyrazole‐clubbed thiophene derivatives via Gewald synthesis as antibacterial and anti‐inflammatory agents	26
Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives	25
Indole/isatin‐containing hybrids as potential antibacterial agents	25
Cinnamic acid hybrids as anticancer agents: A mini‐review	25
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors	25
Anticancer activity of novel 3‐(furan‐2‐yl)pyrazolyl and 3‐(thiophen‐2‐yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies	25
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	25
Synthesis of benzamide derivatives with thiourea‐substituted benzenesulfonamides as carbonic anhydrase inhibitors	24
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	24
N‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies	24
Azetidines of pharmacological interest	24
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	23
Novel 1,2,4‐triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies	23
Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea	22
Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors	22
Design and synthesis of pyrazole–pyrazoline hybrids as cancer‐associated selective COX‐2 inhibitors	22
Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease	21
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds	21
Synthesis of novel sulfonamides with anti‐Alzheimer and antioxidant capacities	21
Ginkgo biloba in the management of the COVID‐19 severity	21
Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis	20
Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents	20
Cytotoxic and antimicrobial potential of benzimidazole derivatives	20
Biscoumarin–pyrimidine conjugates as potent anticancer agents and binding mechanism of hit candidate with human serum albumin	20
Design, synthesis, and biological evaluation of novel morpholinated isatin–quinoline hybrids as potent anti‐breast cancer agents	20
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones	20
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)	19
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors	19
Novel benzo[b]xanthene derivatives: Bismuth(III) triflate‐catalyzed one‐pot synthesis, characterization, and acetylcholinesterase, glutathione S‐transferase, and butyrylcholinesterase inhibitor	19
(+)‐Camphor and (−)‐borneol derivatives as potential anti‐orthopoxvirus agents	19
Reprogramming of antibiotics to combat antimicrobial resistance	18
Anticancer activity of bisindole alkaloids derived from natural sources and synthetic bisindole hybrids	18
1,2,4‐Triazole hybrids with potential antibacterial activity against methicillin‐resistant Staphylococcus aureus	18
1,2,3‐Triazole‐linked 5‐benzylidene (thio)barbiturates as novel tyrosinase inhibitors and free‐radical scavengers	17
Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX‐2/5‐LOX inhibitors	17
Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety	17
Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties	17
Thieno[2,3‐b]pyridine amines: Synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer's disease	16

Design, synthesis, and biological evaluation of imidazopyridine‐linked thiazolidinone as potential anticancer agents	16
(E)‐2‐(2‐Allylidenehydrazinyl)thiazole derivatives: Design, green synthesis, in silico and in vitro antimycobacterial and radical scavenging studies	16
Development of novel indole‐linked pyrazoles as anticonvulsant agents: A molecular hybridization approach	16
Structure–activity relationship studies of indolin‐2‐one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents	16
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	16
The anticancer activity of carbazole alkaloids	15
New N‐phenylacetamide‐linked 1,2,3‐triazole‐tethered coumarin conjugates: Synthesis, bioevaluation, and molecular docking study	15
In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents	15
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif	15
The antimalarial activity of indole alkaloids and hybrids	15
Phyllobilins as a challenging diverse natural product class: Exploration of pharmacological activities	15
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors	15
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies	15
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors	14
Synthesis, characterization, crystal structure, α‐glycosidase, and acetylcholinesterase inhibitory properties of 1,3‐disubstituted benzimidazolium salts	14
Chemical composition and antimicrobial activity of Osage orange (Maclura pomifera) leaf extracts	13
New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies	13
Thiophene‐containing compounds with antimicrobial activity	13
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles	13
Synthesis and anticancer activity of ethyl 5‐amino‐1‐N‐substituted‐imidazole‐4‐carboxylate building blocks	13
Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors	13
New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies	13
Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives	13
Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes	13
PXR–ABC drug transporters/CYP‐mediated ursolic acid transport and metabolism in vitro and vivo	13
Silver–N‐heterocyclic carbene complexes‐catalyzed multicomponent reactions: Synthesis, spectroscopic characterization, density functional theory calculations, and antibacterial study	13
Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations	13
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	12
Effect of substituents in the A and B rings of chalcones on antiparasite activity	12
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models	12
Investigation of HMG‐CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives	12
Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies	12
Novel N‐benzylpiperidine derivatives of 5‐arylisoxazole‐3‐carboxamides as anti‐Alzheimer's agents	12
Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body	12
N‐Substituted pyrimidinethione and acetophenone derivatives as a new therapeutic approach in diabetes	12
Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine‐1,1‐dioxide derivatives	12
Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors	11
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers	11
Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties	11
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation	11
Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study	11
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	11
Synthesis and antimicrobial evaluation of new nitric oxide‐donating fluoroquinolone/oxime hybrids	11
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	11
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids	11
Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine‐2‐thiones as VEGFR‐2 enzyme inhibitors	10
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives	10
Synthesis and evaluation of novel xanthene‐based thiazoles as potential antidiabetic agents	10
Discovery of 2,4‐diaminopyrimidine derivatives targeting p21‐activated kinase 4: Biological evaluation and docking studies	10
Facile synthesis of C6‐substituted benz[4,5]imidazo[1,2‐a]quinoxaline derivatives and their anticancer evaluation	10
Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents	10
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibito	10
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators	10
Cyanopropyl functionalized benzimidazolium salts and their silver N‐heterocyclic carbene complexes: Synthesis, antimicrobial activity, and theoretical analysis	9
Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina	9
In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids	9
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR‐2 inhibitors	9
Design, synthesis, and molecular docking study of novel quinoline‐based bis‐chalcones as potential antitumor agents	9
Evaluation of isoindole derivatives: Antioxidant potential and cytotoxicity in the HT‐29 colon cancer cells	9
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients	9
Antiprotozoal agents: How have they changed over a decade?	9
Influence of the pKa value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects	9
Synthesis of novel 4,5‐dihydropyrrolo[1,2‐a]quinoxalines, pyrrolo[1,2‐a]quinoxalin]‐2‐ones and their antituberculosis and anticancer activity	9
Synthesis and biological evaluation of substituted pyrrolidines and pyrroles as potential anticancer agents	9
Probing simple structural modification of α‐mangostin on its cholinesterase inhibition and cytotoxicity	9
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	9
Current perspectives on naturally occurring saponins as anticancer agents	9
Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies	9
Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity	9
Upregulation of BAX and caspase‐3, as well as downregulation of Bcl‐2 during treatment with indeno[1,2‐b]quinoxalin derivatives, mediated apoptosis in human cancer cells	9
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4‐triazole scaffolds	9
Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease	9
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis	9
Comparison of extraction efficiency and selectivity between low‐temperature pressurized microwave‐assisted extraction and prolonged maceration	9
Synthesis and radioligand‐binding assay of 2,5‐disubstituted thiadiazoles and evaluation of their anticonvulsant activities	9
Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors	8
Bioevaluation of synthetic pyridones as dual inhibitors of α‐amylase and α‐glucosidase enzymes and potential antioxidants	8
Piperazine and piperidine‐substituted 7‐hydroxy coumarins for the development of anti‐inflammatory agents	8
Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue	8
Design and synthesis of benzenesulfonamide‐linked imidazo[2,1‐b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors	8

Insights into the chemistry and therapeutic potential of acrylonitrile derivatives	8
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations	8
A new series of hydrazones as small‐molecule aldose reductase inhibitors	8
Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluation	8
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities	8
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19	8
Synthesis and biological evaluation of coumarin‐thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors	8
Synthesis and biological evaluation of novel isoxazole derivatives from acridone	8
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors	8
Synthesis of new 7‐amino‐3,4‐dihydroquinolin‐2(1H)‐one‐peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities	8
Recent advances in indole dimers and hybrids with antibacterial activity against methicillin‐resistant Staphylococcus aureus	8
Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives	8
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors	8
Synthesis and biological evaluation of Val–Val dipeptide–sulfonamide conjugates	8
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies	8
Synthesis, structural characterization, and biological studies of ATBS–M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents	8
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment	8
A new series of benzoxazole‐based SIRT1 modulators for targeted therapy of non‐small‐cell lung cancer	7
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ	7
Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment	7
Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi	7
Bioevaluation of quinoline‐4‐carbonyl derivatives of piperazinyl‐benzothiazinones as promising antimycobacterial agents	7
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018–2022)	7
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery	7
Design, synthesis, evaluation, and molecular modeling studies of indolyl oxoacetamides as potential pancreatic lipase inhibitors	7
Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors	7
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	7
New nanodrug design for cancer therapy: Its synthesis, formulation, in vitro and in silico evaluations	7
Anti‐inflammatory activity of pyridazinones: A review	7
The antimalarial activity of 1,2,4‐trioxolane/trioxane hybrids and dimers: A review	7
Synthesis and antimicrobial activity of new 2‐piperazin‐1‐yl‐N‐1,3‐thiazol‐2‐ylacetamides of cyclopenta[c]pyridines and pyrano[3,4‐c]pyridines	7
Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies	7
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	7
Synthesis and antitumor potential of new arylidene ursolic acid derivatives via caspase‐8 activation	7
Phthalimide‐tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies	7
Synthesis of new arylazopyrazoles as apoptosis inducers: Candidates to inhibit proliferation of MCF‐7 cells	7
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor	7
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands	7
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	7
Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity	7
Synthesis of new 1,2,4‐triazole–(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis	7
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	7
Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex	7
Development of new Alzheimer's disease drug candidates using donepezil as a key model	7
Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands	7